ArticleCell reports. Medicine2025

Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-α breast cancer risk.

Alana A Arnone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.